WASHINGTON: The Food and Drug Administration (FDA) Sunday issued an emergency authorization for experimental coronavirus treatments using chloroquine and hydroxychloroquine, anti-malaria drugs touted by President Donald Trump despite inconclusive clinical proof of their efficacy.
The Department of Health and Human Services said Sunday hydroxychloroquine and chloroquine products can “be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.”
HHS said Germany’s Sandoz has already given 30 million doses of hydroxychloroquine to the Strategic National Stockpile, the federal government’s inventory of medical supplies for public health emergencies, while Bayer has donated a million doses of chloroquine, reports the international media.
Khawar Manika's counsel continued his arguments on Wednesday in a petition filed by Imran Khan and Bushra Bibi
IHC reserved judgment on the petition against registration of cases against former interior minister Sheikh Rashid on...
Saudi woman who was reportedly kidnapped from Islamabad’s residential Sector F-8 in mysterious circumstances, has...
Pakistan Navy warship rescued 8 Iranian fishermen after their boat caught fire in the open sea
SC dismissed appeal against SHC order that turned down application of partner seeking extension of time to furnish...
Executive board of International Monetary Fund will meet on April 29 to discuss the approval of $1.1 billion funding...
